Radiopharm Theranostics: Could this be the technology that finally kicks cancer to the kerb? -

Listen to ASX-listed Radiopharm Theranostics Executive Chairman and biotech entrepreneur Paul Hopper talk to Matt Birney on the Bulls N’ Bears Report about Radiopharm’s brand new “radiopharmaceutical” product that is being developed to seek, illuminate and destroy cancerous cells without impacting the healthy ones.

See omnystudio.com/listener for privacy information.